Global Expansion Wellthy Therapeutics has recently expanded into the United States with FDA and HIPAA certifications, opening opportunities to collaborate with US healthcare providers and insurers seeking digital therapeutics solutions compliant with strict regulatory standards.

Acquisition & Growth The company has been acquired by TruDoc Healthcare LLC, which indicates strategic growth and increased resources, making it an opportune time to explore partnership or integration opportunities within expanding telehealth ecosystems.

Strong Funding & Market Position With recent investments from Beyond Next Ventures and a revenue range of up to 10 million dollars, Wellthy Therapeutics is positioning itself as a promising player in digital health, attracting potential clients and partners interested in scalable, clinically validated solutions.

Digital Health Certification Achieving validation such as FDA 21 CFR Part 820 and HIPAA compliance signals high-quality, regulatory-approved products, making the company an attractive partner for healthcare organizations pursuing secure and compliant digital therapeutics.

Technological Capabilities Leveraging an advanced tech stack and a versatile platform for disease-agnostic treatments, Wellthy Therapeutics offers scalable solutions that can be tailored for diverse healthcare markets and customer needs, creating multiple sales opportunities globally.